Samsung Biologics Targets Global Dominance with $1.8 Billion Acquisition of PolyPeptide Group
In a strategic maneuver that signals a seismic shift in the Contract Development and Manufacturing Organization (CDMO) landscape, Samsung Biologics...
In a strategic maneuver that signals a seismic shift in the Contract Development and Manufacturing Organization (CDMO) landscape, Samsung Biologics...